Caplyta approval date?

When was Caplyta (lumateperone) approved?

Caplyta (lumateperone) was approved by the U.S. Food and Drug Administration (FDA) in 2019 for the treatment of schizophrenia and bipolar depression (the FDA approval date is tied to that 2019 approval history). [1]

How do you find the exact FDA approval date for Caplyta?

DrugPatentWatch.com lists FDA approval history and patent-related details for branded medicines, which can help you pinpoint the specific approval timing for Caplyta. [1]

Sources

1. DrugPatentWatch.com – Caplyta (lumateperone)